Prognosis of thyroid carcinoma patients with osseous metastases: an SEER-based study with machine learning
- PMID: 36867400
- DOI: 10.1007/s12149-023-01826-z
Prognosis of thyroid carcinoma patients with osseous metastases: an SEER-based study with machine learning
Abstract
Objective: Osseous metastasis (OM) is the second most common site of thyroid cancer distant metastasis and presents a poor prognosis. Accurate prognostic estimation for OM has clinical significance. Ascertain the risk factors for survival and develop an effective model to predict the 3-year, 5-year overall survival (OS) and cancer-specific survival (CSS) for thyroid cancer patients with OM.
Methods: We retrieved the information of patients with OMs between 2010 and 2016 from the Surveillance, Epidemiology, and End Result Program. The Chi-square test, and univariate and multivariate Cox regression analyses were performed. Four machine learning (ML) algorithms, which were most commonly used in this field, were applied.
Result: A total of 579 patients having OMs were eligible. Advanced age, tumor size ≥ 40 mm, combined with other distant metastasis were associated with worse OS in DTC OMs patients. Radioactive iodine (RAI) significantly improved CSS in both males and females. Among four ML models [logistic regression, support vector machines, extreme gradient boosting, and random forest (RF)], RF had the best performance [area under the receiver-operating characteristic curve: 0.9378 for 3-year CSS, 0.9105 for 5-year CSS, 0.8787 for 3-year OS, 0.8909 for 5-year OS]. The accuracy and specificity of RF were also the best.
Conclusions: RF model shall be used to establish an accurate prognostic model for thyroid cancer patients with OM, not only from the SEER cohort but also intended for all thyroid cancer patients in the general population, which may be applicable in clinical practice in the future.
Keywords: Machine learning (ML); Osseous metastases (OMs); Radioactive iodine (RAI); Random forest (RF); Surveillance; Survival; Thyroid carcinoma (TC).
© 2023. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.
Similar articles
-
Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis.Ann Surg Oncol. 2013 Apr;20(4):1329-35. doi: 10.1245/s10434-012-2711-x. Epub 2012 Oct 28. Ann Surg Oncol. 2013. PMID: 23104708 Free PMC article. Clinical Trial.
-
Machine learning based on SEER database to predict distant metastasis of thyroid cancer.Endocrine. 2024 Jun;84(3):1040-1050. doi: 10.1007/s12020-023-03657-4. Epub 2023 Dec 29. Endocrine. 2024. PMID: 38155324
-
Radioactive Iodine Therapy in Patients With Thyroid Carcinoma With Distant Metastases: A SEER-Based Study.Cancer Control. 2020 Jan-Dec;27(1):1073274820914661. doi: 10.1177/1073274820914661. Cancer Control. 2020. PMID: 32292051 Free PMC article.
-
Independent risk factors evaluation for overall survival and cancer-specific survival in thyroid cancer patients with bone metastasis: A study for construction and validation of the predictive nomogram.Medicine (Baltimore). 2020 Sep 4;99(36):e21802. doi: 10.1097/MD.0000000000021802. Medicine (Baltimore). 2020. PMID: 32899008 Free PMC article.
-
Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.Endocrine. 2019 Nov;66(2):254-265. doi: 10.1007/s12020-019-01999-6. Epub 2019 Jul 17. Endocrine. 2019. PMID: 31317522
Cited by
-
Web-based prediction models for predicting overall survival and cancer specific survival in lung metastasis of patients with thyroid cancer: a study based on the SEER database and a Chinese cohort.J Cancer. 2024 Nov 4;15(20):6768-6783. doi: 10.7150/jca.103542. eCollection 2024. J Cancer. 2024. PMID: 39668837 Free PMC article.
-
Bone metastasis in differentiated thyroid cancer: Spanish multicenter study of clinical characteristics, survival and prognostic factors.Front Endocrinol (Lausanne). 2024 Nov 7;15:1466245. doi: 10.3389/fendo.2024.1466245. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39574953 Free PMC article.
References
-
- Siegel R, Miller K, Fuchs H, Jemal A. Cancer statistics, 2022. CA. 2022;72(1):7–33. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical